|
TADA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.103300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.217760E-04 |
| Normal-vs-Stage2 |
2.854400E-01 |
| Normal-vs-Stage3 |
7.340600E-01 |
| Normal-vs-Stage4 |
7.498400E-01 |
| Stage1-vs-Stage2 |
3.333800E-01 |
| Stage1-vs-Stage3 |
5.142100E-02 |
| Stage1-vs-Stage4 |
6.618100E-02 |
| Stage2-vs-Stage3 |
3.523400E-01 |
| Stage2-vs-Stage4 |
3.565200E-01 |
| Stage3-vs-Stage4 |
9.505600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.283700E-03 |
| Normal-vs-AfricanAmerican |
1.095200E-01 |
| Normal-vs-Asian |
2.570300E-02 |
| Caucasian-vs-AfricanAmerican |
7.159800E-01 |
| Caucasian-vs-Asian |
6.681600E-01 |
| AfricanAmerican-vs-Asian |
5.765000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.007680E-04 |
| Normal-vs-Female |
5.892000E-01 |
| Male-vs-Female |
2.558900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.039850E-01 |
| Normal-vs-Extreme_Weight |
4.43989999999728E-05 |
| Normal-vs-Obese |
4.065600E-01 |
| Normal-vs-Extreme_Obese |
1.127400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.944360E-01 |
| Normal_Weight-vs-Obese |
4.572200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.637000E-01 |
| Extreme_Weight-vs-Obese |
2.366000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.336600E-01 |
| Obese-vs-Extreme_Obese |
3.121800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.377000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.608440E-01 |
| Normal-vs-Age(61-80Yrs) |
1.789030E-04 |
| Normal-vs-Age(81-100Yrs) |
4.924300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.516360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.312290E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.530300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.331900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.713650E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.298000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.565000E-04 |
| Normal-VS-Type2 PRCC |
1.038950E-01 |
| Normal-VS-KIRP CIMP |
4.136200E-01 |
| Normal-VS-Unclassified PRCC |
4.117800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.780000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.316850E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.214600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.073970E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.611000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.764620E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.642100E-04 |
| Normal-vs-N1 |
1.157020E-01 |
| Normal-vs-N2 |
1.782250E-01 |
| N0-vs-N1 |
4.143500E-03 |
| N0-vs-N2 |
7.093600E-01 |
| N1-vs-N2 |
2.776600E-01 |
|
|
